Max Robotics — Global Service Robot Directory + US Certification

About

Yingchen Xu is a rising star in the field of biomedical micro/nanorobotics, with a focused research agenda on developing intelligent, magnetically controlled systems for targeted cancer therapy. Xu’s major contributions lie at the intersection of materials science and oncology, pioneering the use of biocompatible ferrofluids and dual-responsive nanoparticles for in vivo applications. In a landmark 2023 study, Xu introduced a biocompatible ferrofluid-based millirobot for tumor photothermal therapy in the near-infrared-II window, a work that has already garnered 13 citations for its novel approach to overcoming the challenge of applying ferrofluidic robots inside the body. Building on this, Xu’s 2024 work on dual-responsive magnetic DCR3 nanoparticles for hepatocellular carcinoma—cited 8 times—represents a significant leap in precision medicine, offering a new strategy to enhance drug targeting efficiency while minimizing systemic side effects. By combining magnetic control with dual responsiveness, Xu is addressing a critical bottleneck in translating micro/nanorobots from in vitro demonstrations to clinical realities. With a clear trajectory toward solving real-world medical challenges, Yingchen Xu is establishing a reputation for engineering smart, biocompatible therapeutic platforms that promise to reshape the future of non-invasive cancer treatment.